Antoine Pascaud-Ouvrard

Rouen, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Managing cardio-renal-metabolic risk in patients with type 2 diabetes: the role of finerenone.

Managing cardio-renal-metabolic risk in patients with type 2 diabetes: the role of finerenone.

Journal: Journal of diabetes and its complications
Published: December 09, 2023

BPIFB4 and its longevity-associated haplotype protect from cardiac ischemia in humans and mice.

BPIFB4 and its longevity-associated haplotype protect from cardiac ischemia in humans and mice.

Journal: Cell death & disease
Published: January 22, 2023

Regulation and impact of cardiac lymphangiogenesis in pressure-overload-induced heart failure.

Regulation and impact of cardiac lymphangiogenesis in pressure-overload-induced heart failure.

Journal: Cardiovascular research
Published: May 11, 2021

Antifibrotic effect of novel neutrophil gelatinase-associated lipocalin inhibitors in cardiac and renal disease models.

Antifibrotic effect of novel neutrophil gelatinase-associated lipocalin inhibitors in cardiac and renal disease models.

Journal: Scientific reports
Published: August 02, 2020

Mineralocorticoid receptor blockade with finerenone improves heart function and exercise capacity in ovariectomized mice.

Mineralocorticoid receptor blockade with finerenone improves heart function and exercise capacity in ovariectomized mice.

Journal: ESC heart failure
Published: July 23, 2020

Transient heart rate reduction improves acute decompensated heart failure-induced left ventricular and coronary dysfunction.

Transient heart rate reduction improves acute decompensated heart failure-induced left ventricular and coronary dysfunction.

Journal: ESC heart failure
Published: June 04, 2020

Myocardial Injury After Ischemia/Reperfusion Is Attenuated By Pharmacological Galectin-3 Inhibition.

Myocardial Injury After Ischemia/Reperfusion Is Attenuated By Pharmacological Galectin-3 Inhibition.

Journal: Scientific reports
Published: February 06, 2019

Protein tyrosine phosphatase 1B inactivation limits aging-associated heart failure in mice.

Protein tyrosine phosphatase 1B inactivation limits aging-associated heart failure in mice.

Journal: American journal of physiology. Heart and circulatory physiology
Published: March 24, 2018

Short- and long-term administration of the non-steroidal mineralocorticoid receptor antagonist finerenone opposes metabolic syndrome-related cardio-renal dysfunction.

Short- and long-term administration of the non-steroidal mineralocorticoid receptor antagonist finerenone opposes metabolic syndrome-related cardio-renal dysfunction.

Journal: Diabetes, obesity & metabolism
Published: March 06, 2018

Mineralocorticoid receptor antagonism improves diastolic dysfunction in chronic kidney disease in mice.

Mineralocorticoid receptor antagonism improves diastolic dysfunction in chronic kidney disease in mice.

Journal: Journal of molecular and cellular cardiology
Published: February 28, 2018

Aldosterone Target NGAL (Neutrophil Gelatinase-Associated Lipocalin) Is Involved in Cardiac Remodeling After Myocardial Infarction Through NFκB Pathway.

Aldosterone Target NGAL (Neutrophil Gelatinase-Associated Lipocalin) Is Involved in Cardiac Remodeling After Myocardial Infarction Through NFκB Pathway.

Journal: Hypertension (Dallas, Tex. : 1979)
Published: May 29, 2017

Vascular Smooth Muscle Mineralocorticoid Receptor Contributes to Coronary and Left Ventricular Dysfunction After Myocardial Infarction.

Vascular Smooth Muscle Mineralocorticoid Receptor Contributes to Coronary and Left Ventricular Dysfunction After Myocardial Infarction.

Journal: Hypertension (Dallas, Tex. : 1979)
Published: November 03, 2015
Showing 1-12 of 17

Last Updated: 09/26/2026